Friday, January 11, 2013

Genetic variation and neuroimaging: some ground rules for reporting research








Those who follow me on Twitter may have
noticed signs of tetchiness in my tweets over the past few weeks. In the course
of writing a review article, I’ve been reading papers linking genetic variants
to language-related brain structure and function. This has gone more slowly than I expected for
two reasons. First, the literature gets ever more complicated and technical:
both genetics and brain imaging involve huge amounts of data, and new methods
for crunching the numbers are developed all the time. If you really want to understand
a paper, rather than just assuming the Abstract is accurate, it can be a long,
hard slog, especially if, like me, you are neither a geneticist nor a
neuroimager. That’s understandable and perhaps unavoidable. The other reason,
though, is less acceptable. For all their complicated methods, many of the
papers in this area fail to tell the reader some important and quite basic
information. This is where the tetchiness comes in. Having burned my brains out
trying to understand what was done, I then realise that I have no idea about
something quite basic like the sample size. The initial assumption is that I’ve
missed it, and so I wade through the paper again, and the Supplementary Material, looking
for the key information. Only when I’m absolutely certain that it’s not there,
am I reduced to writing to the authors for the information. So
this is a plea – to authors, editors and reviewers. If a paper is concerned
with an association between a genetic variant and a phenotype (in my case the
interest is in neural phenotypes, but I suspect this applies more widely) then
could we please ensure that the following information is clearly reported in
the Methods or Results section





1. What genetic variant are we talking about?
You might think this is very simple, but it’s not: for instance, one of the
genes I’m interested in is CNTNAP2, which has been associated with a range of
neurodevelopmental disorders, especially those affecting language. The evidence
for a link between CNTNAP2 and developmental disorders comes from studies that
have examined variation in single-nucleotide polymorphisms or SNPs. These are
segments of DNA that are useful in revealing differences between people because
they are highly variable. DNA is composed of four bases, C, T, G, and A in
paired strands. So for instance, we might have a locus where some people have
two copies of C, some have two copies of T, and others have a C and a T. SNPs
are not  necessarily a functional part of
the gene itself – they may be in a non-coding region, or so close to a gene that
variation in the SNP co-occurs with variation in the gene. Many different SNPs
can index the same gene. So for CNTNAP2, Vernes et al (2008)tested 38 SNPs,
ten of which were linked to language problems. So we have to decide which SNP
to study – or whether to study all of them. And we have to decide how to do the
analysis. For instance, SNP rs2710102 can take the form CC, CT or TT. We could
look for a dose response effect (CC < CT < TT) or we could compare CC/CT with TT, or we could compare CC with CT/TT. Which of these we do may depend on whether prior research suggests the genetic effect is additive or dominant, but for brain imaging studies grouping can also be dictated by practical considerations: it’s usual to compare just two groups and to combine genotypes to give a reasonable sample size. If you’ve followed me so far, and you have some background in statistics, you will already be starting to see why this is potentially problematic. If the researcher can select from ten possible SNPs, and two possible analyses, the opportunities for finding spuriously ‘significant’ results are increased. If there are no directional predictions – i.e. we are just looking for a difference between two groups, but don’t have a clear idea of what type of difference will be associated with ‘risk’ – then the number of potentially ‘interesting’ results is doubled.


For CNTNAP2, I found two papers that had
looked at brain correlates of SNP rs2710102. Whalley et al (2011) found that adults
with the CC genotype had different patterns of brain activation from CT/TT
individuals. However, the other study, by Scott-van Zeeland et al (2010), treated
CC/CT as a risk genotype that was compared with TT. (This was not clear in the
paper, but the authors confirmed it was what they did).




 Four studies looked at another SNP -
rs7794745, on the basis that an increased risk of autism had been reported for
the T allele in males. Two of them (Tan et al, 2010; Whalley et al, 2010) compared TT vs TA/AA and two (Folia et al, 2011; Kos et al, 2012) compared
TT/TA with AA. In any case, the ground is rather cut from under the feet of
these researchers by a recent failure to replicate an association of this SNP
with autism (Anney et al, 2012).







2. Who are the participants? It’s not very
informative to just say you studied “healthy volunteers”. There are some types
of study where it doesn’t much matter how you recruited people. A study looking
at genetic correlates of cognitive ability isn’t one of them. Samples of
university students, for instance, are not representative of the general
population, and aren’t likely to include many people with significant language
problems.





3. How many people in the study had each type
of genetic variant?
And if subgroup analyses are reported, how many people in
each subgroup had each type of genetic variant? I've found that papers in top-notch journals often fail to provide this basic
information.


Why is this important? For a start, likelihood
of showing significant activation of a brain region will be affected by sample
size. Suppose you have 24 people with genotype A and 8 with genotype B. You
find significant activation of brain region X in those with genotype A, but not
for those with genotype B. If you don’t do an explicit statistical comparison
of groups (you should - but many people don’t) you may be misled into concluding that brain
activation is defective in genotype B – when in fact you just have low power to
detect effects in that group because it is so small.




In addition, if you don’t report the N, then
it’s difficult to get an idea of the effect size and confidence interval for
any effect that is reported. The reasons why this is optimal are
well-articulated here. This issue has been much discussed in psychology, but seems not to have
permeated the field of genetics, where reliance on p-values seems the norm. In
neuroimaging it gets particularly complicated, because some form of correction
for ‘false discovery’ will be applied when multiple comparisons are conducted. It’s
often hard to work out quite how this was done, and you can end up staring at
a table that shows brain regions and p-values, with only a vague idea of how
big a difference there actually is between groups.




 Most of the SNPs that are being used in brain studies are ones that
were found to be associated with a behavioural phenotype in large-scale genomic
studies where the sample size would include hundreds if not thousands of
individuals, so small effects could be detected. Brain-based studies often use
sample sizes that are relatively small, but some of them find large, sometimes
very large, effects. So what does that mean? The optimistic interpretation is
that a brain-based phenotype is much closer to the gene effect, and so gives
clearer findings. This is essentially 
the argument used by those who talk of ‘endophenotypes’ or ‘biomarkers’.
There is, however, an alternative, and much more pessimistic view, which is
that studies linking genotypes with brain measures are prone to generate false
positive findings, because there are too many places in the analysis pipeline
where the researchers have opportunities to pick and choose the analysis that
brings out the effect of interest most clearly. Neuroskeptic has a nice blogpost illustrating this well-known problem in
the neuroimaging area; matters are only made worse by uncertainty re SNP classification
(point 1).






A source of concern here is the
unpublishability of null findings. Suppose you did a study where you looked at,
say, 40 SNPs and a range of measures of brain structure, covering the whole
brain. After doing appropriate corrections for multiple comparisons, nothing is
significant. The sad fact is that your study is unlikely to find a home in a
journal. But is this right? After all, we don’t want to clutter up the
literature with a load of negative results. The answer depends on your sample
size, among other things. In a small sample, a null result might well reflect
lack of statistical power to detect a small effect. This is precisely why
people should avoid doing small studies: if you find nothing, it’s
uninterpretable. What we need are studies that allow us to say with confidence
whether or not there is a significant gene effect.





4. How do the genetic/neuroimaging results relate to cognitive measures in your sample?  Your notion that ‘underactivation of brain area
X’ is an endophenotype that leads to poor language, for instance, doesn’t look
very plausible if people who have such underactivation have excellent language skills. Out
of five papers on CNTNAP2 that I reviewed, three made no mention of cognitive measures,
one gathered cognitive data but did not report how it related to genotype or
brain measures, and only one provided some relevant, though sketchy, data.





5. Report negative findings. The other kind of
email I’ve been writing to people is one that says – could you please clarify
whether your failure to report on the relationship between X and Y was because
you didn’t do that analysis, or whether you did the analysis but failed to find
anything. This is going to be an uphill battle, because editors and reviewers
often advise authors to remove analyses with nonsignificant findings. This is a
very bad idea as it distorts the literature.









And last of all....


A final plea is not so much to journal
editors as to press officers. Please be aware that studies of common SNPs aren't the same as studies of rare genetic mutations. The genetic variants in the
studies I looked at were all relatively common in the general population, and so
aren't going to be associated with major brain abnormalities. Sensationalised
press releases can only cause confusion:


This release on the Scott van-Zeeland (2010) study described neuroimaging
findings from  CNTNAP2 variants that are found in over 70% of the population. It claims that:
 


  • “A gene variant tied to autism rewires the
    brain"



  • "Now we can begin to unravel the mystery
    of how genes rearrange the brain's circuitry, not only in autism but in many
    related neurological disorders."



  • “Regardless of their diagnosis, the children
    carrying the risk variant showed a disjointed brain. The frontal lobe was
    over-connected to itself and poorly connected to the rest of the brain”



  • "If we determine that the CNTNAP2
    variant is a consistent predictor of language difficulties, we could begin to
    design targeted therapies to help rebalance the brain and move it toward a path
    of more normal development."



Only at the end of the press release, are we
told that "One third of the population [sic: should be two thirds] carries this variant in its DNA.
It's important to remember that the gene variant alone doesn't cause autism, it
just increases risk." 




References


Anney, R., Klei, L.,
Pinto, D., Almeida, J., Bacchelli, E., Baird, G., . . . Devlin, B. .
Individual common variants exert weak effects on the risk for autism spectrum
disorders. Human Molecular Genetics, 21(21), 4781-4792. doi: 10.1093/hmg/dds301(2012)

V. Folia, C. Forkstam, M.
Ingvar, P. Hagoort, K. M. Petersson, Implicit artificial syntax processing:
Genes, preference, and bounded recursion. Biolinguistics 5,  (2011).




M. Kos et al., CNTNAP2
and language processing in healthy individuals as measured with ERPs. PLOS One
7,  (2012).

Scott-Van Zeeland, A., Abrahams, B., Alvarez-Retuerto, A., Sonnenblick, L., Rudie, J., Ghahremani, D., Mumford, J., Poldrack, R., Dapretto, M., Geschwind, D., & Bookheimer, S. (2010). Altered Functional Connectivity in Frontal Lobe Circuits Is Associated with Variation in the Autism Risk Gene CNTNAP2 Science Translational Medicine, 2 (56), 56-56 DOI: 10.1126/scitranslmed.3001344





G. C. Tan, T. F. Doke, J.
Ashburner, N. W. Wood, R. S. Frackowiak, Normal variation in fronto-occipital
circuitry and cerebellar structure with an autism-associated polymorphism of
CNTNAP2. Neuroimage 53, 1030 (2010).




Vernes, S. C., Newbury,
D. F., Abrahams, B., Winchester, L., Nicod, J., Groszer, M., . . . Fisher, S.  A functional genetic link between distinct developmental language
disorders. New England Journal of Medicine, 359, 2337-2345. (2008).




H. C. Whalley et al.,
Genetic variation in CNTNAP2 alters brain function during linguistic processing
in healthy individuals. Am. J. Med. Genet. B 156B, 941 (2011).

Saturday, December 22, 2012

Genes, brains and lateralisation: how solid is the evidence?






If there were a dictionary of famous neurological quotes, “Nous parlons avec l'hémisphère gauche” by Paul Broca (1865) would be up there among the top hits. Broca’s realisation that the two sides of the brain are functionally distinct was a landmark observation. It was based on a rather small series of patients, but has since been confirmed in numerous studies. After localised brain injury, aphasia (language impairment) is far more likely after damage to the left side than the right side. And nowadays, we can visualise greater activation of the left side in neurologically intact people as they do language tasks in a brain scanner.



There are many fascinating features of cerebral lateralisation, but I’m going to focus here on just one specific question: what do we know about genetic influences on brain asymmetry in humans?  There are really two questions here: (1) how do genes lead to asymmetric brain development? (2) are there genetic variants that can account for individual variation?  – e.g. the fact that a minority of people have right hemisphere language. I hope to return to question 2 at a later date, but for now, I’ll focus on question 1, because after reading a key paper on this topic, I've struck a whole load of questions that I can’t answer. I’m hoping that some of my genetically-sophisticated readers will be able to help me out.



It’s sometimes stated that cerebral lateralisation is a uniquely human trait, but that’s not true. Nevertheless, we are very different from our primate cousins, insofar as we show a strong population bias to right-handedness, and most people have left-hemisphere language. There are other species which show consistent brain asymmetries, but they are a long way from us on the evolutionary tree. Most of the research I’ve come across is on nematode worms, zebrafish, or songbirds. This is a long way from my comfort zone, but there are some nice reviews that document research on genes influencing asymmetries in these creatures (e.g. here and here). It’s clear, though, that it’s complicated: not just in terms of the range of genes involved, but in the different ways they can generate asymmetry. And there don't seem to be obvious parallels to human brain development.



Despite all this uncertainty, there’s growing evidence that brain asymmetries are present from very early on in life –in newborn babies and even in foetal life. This field is still in its infancy (forgive the pun), and samples of babies are typically too small to reveal reliable relationships between structure and function. Nevertheless, there’s considerable interest in the idea that physical differences between the two sides of the brain may be an indicator of potential for language development.



A particularly exciting topic is genetic determinants of cerebral lateralisation. One study in particular, by Sun et al made a splash when it was published in Science in 2005, since when it has attracted over 140 citations. The authors looked for asymmetric gene expression in post mortem embryonic brains. Their conclusions have been widely cited: “We identified and verified 27 differentially expressed genes, which suggests that human cortical asymmetry is accompanied by early, marked transcriptional asymmetries.” The fact that several different genes were identified was of particular interest to me, because genetic theories by neuropsychologists have typically assumed that just a single gene is responsible for human cerebral lateralisation. I’ve never found a single-gene theory plausible, so I was all too ready to accept evidence that involved multiple genes. But first I wanted to drill down deeper into the methods to find out how the authors reached their conclusions. I’m a psychologist, not a geneticist, and so this was rather challenging. But my deeper reading raised a number of questions.



Sun et al used a method called Serial Analysis of Gene Expression (SAGE) which compares gene expression in different tissues or – as in this case – in corresponding left and right regions of the embryonic brain. The analysis looks for specific sequences of 10 DNA base-pairs, or tags, which index particular genes. SAGE output consists of simple tables, giving the identity of each tag, its count (a measure of cellular gene expression) and an identifier and more detailed description of the corresponding gene. These tables are available for left and right sides for three brain regions (frontal, perisylvian and occipital) for 12- and 14-week old brains, and for perisylvian only for a 19-week-old brain. The perisylvian region is of particular interest because it is the brain region that will develop into the planum temporale, which has been linked with language development.  One brain at each age was used to create the set of SAGE tags.



To identify asymmetrically expressed genes the authors state performed a Monte Carlo test and verified this using the chi square test. I haven’t tracked down the specifics of the Monte Carlo test, which is part of the SAGE software package, but the chi square is pretty straightforward, and involves testing whether the distribution of expression on left and right is significantly different from the distribution of left vs. right expression across all tags in this brain region – which is close to 50%.  In the left-right perisylvian region of a 12-week-old embryonic human brain, there were 49 genes with chi square greater than 6.63 (p < .01): 21 were more highly expressed on the left and 28 more highly expressed on the right.  But for each region the authors considered several thousand tags. So I wondered whether the number of asymmetrically expressed genes was any different from what you’d expect if asymmetry was just arising by chance.



It was possible to check this out from the giant supplementary Excel files that accompany the paper, but this proved far from straightforward.  It turns out that the relationship between tags and genes is not one-to-one.  For around 40% of the tags, there is more than one corresponding gene. It was not clear which gene was selected in such cases, and why. I did find some cases where two genes were assigned to a tag, but my impression was that this was unintentional and in general the authors aimed to avoid double-counting tags. We also have the further problem that some genes are indexed by numerous tags, a point I will return to below.



But let’s just focus first on the individual tags. I compiled a master list of all tags that were expressed in any region at any age, and then made a chart of the frequency of expression in each brain region/age. I excluded any tags where the total expression count on both sides was three or less, as this is too small to show lateralisation, and this left me with 3800 to 4600 tags for analysis in each brain region. I did compute chi square as described by Sun et al, but this is not recommended for small numbers, and so I also evaluated the significance of asymmetry using a two-tailed binomial test. This doesn’t make a huge difference, but is more accurate when comparing small numbers.  Figure 1 shows the proportion of the sample for each brain region where the binomial test gives a p-value of a given size. If the distribution of expression in left and right was purely determined by chance, we’d expect the points to fall on the line. If there were genes for asymmetry we would expect the observed values to fall above the line, especially at low levels of p. It is clear this is not the case. I did cross-check my figures against those of Sun et al, and found they appeared to have missed some cases of significant asymmetry, which meant that in general they found rather fewer cases of significant asymmetry than are shown in Figure 1.






Fig 1. Proportion of tags with "significant" asymmetry, by Age/Brain Region



Sun et al didn’t rely solely on statistical tests of SAGE data to establish asymmetrical expression.  They reported validation studies using a different method for assessing gene expression (real-time PCR). But this used genes selected on the basis of a chi square value of 1.9 or greater (P < .17), which included many where the degree of asymmetry was not large. One goal of PCR analysis was to confirm asymmetric expression levels in the same embryonic brains as the SAGE analysis. Of more interest is whether the findings generalise to new brains. The authors did further cross-validation using real-time PCR with six additional brains of different ages, and reported results for the LMO4 gene, where higher perisylvian expression on the right was evident in two brains at 12 and 14 weeks of age, as well as in the original two brains of the same age. Four other brains, aged 16 to 19 months, did not show asymmetry of expression. Some of the other asymmetrically expressed genes were also tested using real-time PCR in the two other brains, and 27 showed consistent asymmetric expression. It was, however, not clear to me how the significance of asymmetry was assessed in these replication samples.



There is one particular issue I find confusing when I try to evaluate the robustness of the asymmetry results. My expectation was that if a gene was asymmetrically expressed, then this should be evident in all the tags indexing that gene. But Table 1 shows that this isn’t so. For the LMO4 gene, which is the focus of special attention in this paper, there are seven tags that are linked with the gene in at least one brain region: only one of these (in red) shows the rightward asymmetry that is the focus of the paper. Another tag (in blue) shows leftward asymmetry in one sample, and the rest have low levels of expression. Maybe there’s a simple explanation for this – if so I hope that expert geneticists among my readers may be able to comment on this aspect.




Table 1. Left- and right-expression levels for seven tags for the LMO4 gene

I’m aware of two other studies (here and here) that looked for asymmetric gene expression in embryonic human brains but failed to find it . One possible reason for this discrepancy is that these studies focused on later stages of development, rather than the 12-14 week-old period where Sun et al found asymmetry. In addition, power is always low in these studies because of the small number of brains available. As Lambert et al (2011) noted, as well as possible effects of age and gender, there may be individual variation from brain to brain, but typically only one or two samples are available at each age.



So what do I conclude from all of this? I realise for a start that these studies are very hard to do. I also realise we have to make a start somewhere, even if the amount of post mortem material is limited. But I have to say I’m not convinced from the evidence so far that the researchers have demonstrated significant asymmetry of genetic expression in embryonic brains. The methods seem to take insufficient account of the possibility of chance fluctuations in the measurements, and the numbers of asymmetries that have been found don't seem impressive, given the huge number of genes that were investigated. Clearly, something has to be responsible for the physical asymmetries that have been found in foetal and neonatal brains, and the odds seem high that genes are implicated. But is the evidence from Sun et al convincing enough to conclude that we have found some of those genes? I'd love to hear views from readers who have more expertise in this area of research.



P.S. 7th Jan 2013

Thanks to Silvia Paracchini, who drew my attention to further relevant articles:

Johnson, M. B., et al (2009). Functional and evolutionary insights into human brain development through global transcriptome analysis. Neuron, 62(4), 494-509. doi: 10.1016/j.neuron.2009.03.027
This paper looked at a slightly later developmental stage - 18 to 23 weeks gestational age - and did correct for the number of genes considered (False Discovery Rate). They reported striking symmetry of gene expression in the mid-gestational
period, even though structural brain asymmetries have been described at this
stage of development. Note, however, that this is not incompatible with Sun et al, who did not find evidence of asymmetry after 17 weeks gestational age.


Kang, H. J., et al (2011). Spatio-temporal transcriptome of the human brain. Nature, 478(7370), 483-489. 

This is a much larger study, covering the range from 4 weeks gestational age through childhood up to adulthood and old age. This paper does not explicitly report on asymmetry, but they describe genes where the expression varies from brain region to region, or from age to age, after adjustment for False Discovery Rate. I could find no overlap in the list of the genes identified by Sun et al and Kang et al's list of differentially expressed genes.



References 



Abrahams, B. S., Tentler, D., Peredely, J. V., Oldham, M. C., Coppola, G., & Geschwind, D. H. (2007). Genome-wide analyses of human perisylvian cerebral cortical patterning. Proceedings of the National Academy of Sciences, 104, 17849-17854.
 


Dehaene-Lambertz, G., Hertz-Pannier, L., & Dubois, J. (2006). Nature and nurture in language acquisition: anatomical and functional brain-imaging studies in infants. Trends in Neurosciences, 29, 367-373.
 


Kivilevitch, Z., Achiron, R., & Zalel, Y. (2010). Fetal brain asymmetry: in utero sonographic study of normal fetuses. American Journal of Obstetrics and Gynecology, 202(4). doi: 359.e1
10.1016/j.ajog.2009.11.001
 


Lambert, N., Lambot, M.-A., Bilheu, A., Albert, V., Englert, Y., Libert, F., . . . Vanderhaeghen, P. (2011). Genes expressed in specific areas of the human fetal cerebral cortex display distinct patterns of evolution. PLOS One, 6(3), e17753. doi: 10.1371/journal.pone.0017753
 


Lash, A. E., Tolstoshev, C. M., Wagner, L., Schuler, G. D., Strausberg, R. L., Riggins, G. J., & Altschul, S. F. (2000). SAGEmap: A public gene expression resource. Genome Research, 10(7), 1051-1060. doi: 10.1101/gr.10.7.1051
 


Sagasti, A. (2007). Three ways to make two sides: Genetic models of asymmetric nervous system development. Neuron, 55(3), 345-351. doi: 10.1016/j.neuron.2007.07.015
 


Sun T, Patoine C, Abu-Khalil A, Visvader J, Sum E, Cherry TJ, Orkin SH, Geschwind DH, & Walsh CA (2005). Early asymmetry of gene transcription in embryonic human left and right cerebral cortex. Science (New York, N.Y.), 308 (5729), 1794-8 PMID: 15894532



Sun, T., & Walsh, C. A. (2006). Molecular approaches to brain asymmetry and handedness. Nature Reviews Neuroscience, 7, 655-662.
 

Saturday, December 15, 2012

Psychology: Where are all the men?





There's a lot of interest in under-representation of women in certain science subjects, but in psychology, there's more concern about a lack of men. A quick look at figures from UCAS (Universities & Colleges Admissions Service) shows massive differences in gender ratios for different subjects. In figure 1 I’ve plotted the percentage of women accepted for subjects that had at least 6000 successful applicants to degree courses in 2011.






Fig. 1. % Females accepted on popular UK degree courses 2011

Given the large sample sizes, the sex differences are statistically
significant for all subjects except Media Studies, which is bang on 50%.
As a psychologist, I found the most surprising thing about this plot
was the huge preponderance of women in psychology. This didn’t square
with my experiences: my colleagues include a good mix of men and women,
so I was keen to find the explanation for the mismatch. There seemed to be several possible explanations, which aren’t mutually exclusive, namely:


  • Oxford University, where I work, may be biased in favour of men

  • The proportions of women decline with career stage

  • The proportion of women in psychology may have increased since I was a student

  • The proportion of women may vary with sub-area of psychology


So I set off to track down the evidence for these different explanations.


Is Oxford University biased against women?


I’m leading our department’s Athena SWAN panel, whose remit is to identify and remove barriers to women’s progress in scientific careers. In order to obtain an Athena SWAN award, you have to assemble a lot of facts and figures about the proportions of women at different career stages, and so I already had at my fingertips some relevant statistics. (You can find these here). Over the past three years, our student intake ranged from 66% -71% women: rather lower than the UCAS figure of 78%. However, acceptance rates were absolutely equivalent for men and women. The same was true for staff appointments: the likelihood of being accepted for a job did not differ by gender. So with a sigh of relief I think we can exclude this line of explanation.


Does the proportion of women in psychology decline with career stage?


I have a research post and so don’t do much teaching. Have I got a distorted view of the gender ratios because my interactions are mostly with more senior staff? This looks believable from the data on our department. Postgraduate figures ranged from 65%-70% women. Ours is a small department, and so it is difficult to be confident in trends, but in 2011 there were 16/27 (59%) female postdocs, 6/11 (55%) female lecturers, 6/13 (46%) senior researchers and 4/11 (36%) female professors. This trend for the proportion of women to decline as one advances through a career is in line with what has been observed in many other disciplines. We also obtained data from other top-level psychology departments for comparison, and similar trends were seen.


Has the proportion of women in psychology increased over time?


My recollection of my undergraduate days was that male psychology students were plentiful. However, I was an undergraduate in the dark ages of the early 1970s when there were only five Oxford colleges that accepted women, and a corresponding shortage of females in all subjects. So I had a dig around to try to get more data. The UCAS statistics go back only to 1996, and the proportion of women in psychology hasn’t changed: 78% in 1996, 78% in 2011. However, data from the USA show a sharp increase in the proportion of women obtaining psychology doctorates from 1960 (18%) through 1972 (27%) to 1984 (50%). This, of course, is in part a consequence of the increase of women in higher education in general. But that isn’t a total explanation: Figure 2 compares proportions of female PhDs over time in different subject areas, and one can see that psychology shows a particularly pronounced increase compared with other disciplines.




Fig 2. Percentages of PhDs by women in the USA: 1950-1984




Does the proportion of women in psychology vary with sub-area?


The term ‘psychology’ covers a huge range of subject matter with different historical roots. Most areas of academic psychology make some use of statistics, but they vary considerably in how far they require strong quantitative or computational skills. For instance, it would be difficult to specialise in the study of perception or neuroscience without being something of a numbers nerd: that’s generally less true for developmental, clinical, interpersonal or social psychology, which require other skills sets. I looked at data from the American Psychological Association (APA), which publishes the numbers of members and fellows in its different Divisions. The APA is predominantly a professional organisation, and non-applied areas of psychology are not strongly represented in the membership. Nevertheless, one can see clear gender differences, which generally map on to the expectation that women are more focused on the caring professions, and men are more heavily represented in theoretical and quantitative areas. Figure 3 shows relevant data for sections with at least 700 members. It is also worth noting that the graph illustrates the decrease in the proportions of women going from membership to fellowship, a trend bucked by just one Division.




Fig 3. Data from American psychological association: Division membership 2011


What, if anything, should we do?


The big question is how far we should try to manipulate gender differences when we find them. I’ve barely scratched the surface in my own discipline, psychology, yet it’s evident that the reasons for such differences are complex. Figure 2 alone makes it clear that women in Western societies have come a long way in the past half-century: far more of us go to university and do PhDs than was the case fifty years ago. Yet the proportion of women declines as we climb the career ladder. In quantifying this trend, it’s important to compare like with like: those who are in senior positions now are likely to have trained at a time when the gender ratio was different. But it's clear from many surveys that demographics changes can't explain the dearth of women in top jobs: there are numerous reasons why women are more likely than men to leave an academic career – see, for instance, this depressing analysis of reasons why women leave chemistry. In our department we are committed to taking steps to ensure that gender does not disadvantage women who want to pursue an academic career, and I am convinced that with even quite minor changes in culture we can make a difference.



The point I want to stress here, though, is that I see this issue - creating a female-friendly environment for women in psychology-  as separate from the issue of subject preference. I worry that the two issues tend to get conflated in discussions of gender equality. My personal view is that psychology is enriched by having a mix of men and women, and I share the concerns expressed here about difficulties that arise when the subject becomes heavily biased to one gender. However, I am pretty uncomfortable with the idea of trying to steer people’s career choices in order to even out a gender imbalance.



Where this has been tried, my impression is that it's mostly been in the direction of trying to encourage more girls into male-dominated subjects. In effect, the argument is that girl's preferences  are based on wrong information, in that they are unduly influenced by stereotypes. For instance, the Institute of Physics has done a great deal of work on this topic, and they have shown that there are substantial influences of schooling on girls’ subject choices. They concluded that the weak showing of girls in physics can be attributed to lack of inspirational teaching, and a perception among girls that physics is a boys’ subject. They have produced materials to help teachers overcome these influences, and we’ll have to wait and see if this makes any appreciable difference to the proportions of girls taking up the subject (which according to UCAS figures has been pretty stable for 15 years: 19% in 1996 and 18% in 2011).



It's laudable that the Institute of Physics is attempting to improve the teaching of physics in our schools, and to ensure girls do not feel excluded. But if they are right, and gender stereotyping is a major determinant of subject choices, shouldn’t we then adopt similar policies to other subjects that show a gender bias, whether this be in favour of girls or boys?



Interestingly, Marc Smith has produced relevant data in relation to A-level psychology, which is dominated by girls, and perceived by boys as a ‘girly’ subject. So should we try to change that? As Smith notes, the female bias seems linked to a preference for schools to teach A-level psychology options that veer away from more quantitative cognitive topics. Here we find that psychology provides an interesting test case for arguments around gender, because within the subject there are consistent biases for males and females to prefer one kind of sub-area to another. This implies that to alter the gender balance you might need to change what is taught, rather than how it is taught, by giving more prominence to the biological and cognitive aspects of psychology. If true, it might be easier to alter gender ratios in psychology than in physics, but only by modifying the content of the syllabus.



One of the IOP's recommendations is: "Co-ed schools should have a target to
exceed the current national average of 20% of physics A-level students
being girls." But surely this presumes an agenda whereby we aim for
equality of genders in all subjects, with equivalent campaigns to
recruit more boys into nursing, psychology and English? I'm not saying
this would necessarily be a bad thing, but I wonder at the automatic assumption that it has to be a good thing - or even an achievable thing. There are obvious disadvantages of gender imbalances in any subject area - they simply reinforce stereotypes, while at the same time creating challenges at university and in the workplace for those rare individuals who buck the trend and take a
gender-atypical subject. But the kinds of targets set by the IOP make me uneasy nonetheless. The downside of an insistence on gender balance is a sense of coercion, whereby children are made to feel that their choice of subject isn't a real choice, but is only made because they  have been brainwashed by gender stereotypes. Yes, let's do our best to teach boys and girls in an inspiring and gender-neutral fashion, but, as the example of psychology demonstrates, we are still likely to find that females and males tend to prefer different kinds of subject matter.



References
 

Smith, M (2011). Failing boys, failing psychology The Psychologist, 24 (5), 390-391 Other: WOS:000290745000037
 



Howard, A., & et al, . (1986). The changing face of American psychology: A report from the Committee on Employment and Human Resources. American Psychologist, 41 (12), 1311-1327 DOI: 10.1037//0003-066X.41.12.1311

Wednesday, November 21, 2012

Moderate drinking in pregnancy: toxic or benign?



There’s no doubt that getting tipsy while pregnant is a seriously bad idea. Alcohol is a toxin that can pass through the placenta to the foetus and cause damage to the developing brain.  For women who are regular heavy drinkers or binge drinkers, there is a risk that the child will develop foetal alcohol syndrome, a condition that affects physical development and is associated with learning difficulties.

But what of more moderate drinking? The advice is conflicting. Many doctors take the view that alcohol is never going to be good for the developing foetus and they recommend complete abstention during pregnancy as a precautionary measure. Others have argued, though, that this advice is too extreme, and that moderate drinking does not pose any risk to the child.



Last week a paper by Lewis et al was published in PLOS One providing evidence on this issue, and concluding that moderate drinking does pose a risk and should be avoided. The methodology of the paper was complex and it’s worth explaining in detail what was done.



The researchers used data from ALSPAC, a large study that followed the progress of several thousand British children from before birth. A great strength of this study is that information was gathered prospectively: in the case of maternal drinking, mothers completed questionnaires during pregnancy, at 18 and 32 weeks gestation.  Obviously, the data won’t be perfect: you have to rely on women to report their intake honestly, but it’s hard to see how else to gather such data without being overly intrusive. When children were 8 years old, they were given a standard IQ test, and this was the dependent variable in the study.



One obvious thing to do with the data would be to see if there is any relationship between amount drank in pregnancy and the child’s IQ. Quite a few studies have done this and a recent systematic review concluded that, provided one excluded women who drank more than 12 g (1.5 UK units) per day or who were binge-drinkers, there was no impact on the child. Lewis et al pointed out, however, that this is not watertight, because drinking in pregnancy is associated with other confounding factors. Indeed, in their study, the lowest IQs were obtained by children of mothers who did not drink at all during pregnancy. However, these mothers were also likely to be younger and less socially-advantaged than mothers who drank, making it hard to disentangle causal influences.



So this is where the clever bit of the study design came in, in the shape of mendelian randomisation. The logic goes like this: there are genetic differences between people in how they metabolise alcohol. Some people can become extremely drunk, or indeed ill, after a single drink, whereas others can drink everyone else under the table. This relates to variation in a set of genes known as ADH genes, which are clustered together on chromosome 4. If a woman metabolises alcohol slowly, this could be particularly damaging to the foetus, because alcohol hangs around in the bloodstream longer. There are quite large racial differences in ADH genes, and for that reason the researchers restricted consideration just to those of White European background. For this group, they showed that variation in ADH genes is not related to social background. So they had a very specific prediction: for women who drank in pregnancy, there should be a relationship between their ADH genes and the child’s outcome. However, if the woman did not drink at all, then the ADH genotype should make no difference. This is the result they reported. It’s important to be clear that they did not directly estimate the impact of maternal drinking on the child’s IQ: rather, they inferred that if ADH genotype is associated with child’s IQ only in drinkers, then this is indirect evidence that drinking is having an impact. This is a neat way of showing that there is an effect of a risk factor (alcohol consumption) avoiding the complications of confounding by social class differences.



Several bloggers, however, were critical of the study. Skeptical Scalpel noted that the effect on IQ was relatively small and not of clinical significance. However, in common with some media reports, he seems to have misunderstood the study and assumed that the figure of 1.8 IQ points was an estimate of the difference between drinkers and abstainers – rather than the effect of ADH risk alleles in drinkers (see below). David Spiegelhalter pointed out that there was no direct estimate of the size of the effect of maternal alcohol intake. Indeed, when drinkers and non-drinkers were directly compared, IQs were actually slightly lower in non-drinkers. Carl Heneghan also commented on the small IQ effect size, but was particularly concerned about the statistical analysis, arguing that it did not adjust adequately for the large number of genetic variants that were considered.



Should we dismiss effects because they are small? I’m not entirely convinced by that argument. Yes, it’s true that IQ is not a precise measure: if an individual child has an IQ of 100, there is error of measurement around that estimate so that the 95% confidence interval is around 95-105 (wider still if a short form IQ is used, as was the case here). This measurement error is larger than the per-allele effects reported by Lewis et al., but they were reporting means from very large numbers of children. If there are reliable differences between these means, then this would indicate a genuine impact on cognition, potentially as large as 3.5 IQ points (for those with four rather than two risk alleles). Sure, we should not alarm people by implying that moderate drinking causes clinically significant learning difficulties, but I don’t think we should just dismiss such a result. Overall cognitive ability is influenced by a host of risk factors, most of which are small, but whose effects add together. For a child who already has other risks present, even a small downwards nudge to IQ could make a difference.



But what about Heneghan’s concern about the reliability of the results? This is something that also worried me when I scrutinised Table 1, which shows for each genetic locus the ‘per allele’ effect on IQ. I’ve plotted the data for child genotypes in Figure 1. Only one SNP (#10) seems to have a significant effect on child IQ. Yet when all loci were entered into a stepwise multiple regression analysis, no fewer than four child loci were identified as having a significant effect. The authors suggested that this could reflect interactions between genes that are on the same genetic pathway.




Effect of child SNP variants (per allele) on IQ (in IQ points), with 95% CI, from Lewis et al Table 1,



I had been warned about stepwise regression by those who taught me statistics many years ago. Wikipedia has a section on Criticisms, noting that results can be biased when many variables are included as predictors. But I found it hard to tell just how serious a problem this was. When in doubt, I find it helpful to simulate data, and so that is what I did in this case, using a function in R that generates multivariate normal data. So I made a dataset where there was no relationship between any of 11 variables – ten of which were designated as genetic loci, and one as IQ. I then ran backwards stepwise regression on the dataset. I repeated this exercise many times, and was surprised at just how often spurious associations of IQ with ‘genotypes’ was seen (as described here). I was concerned that this dataset was not a realistic simulation, because the genotype data from Lewis et al consisted of counts of how many uncommon alleles there were at a given locus (0, 1 or 2 – corresponding to aa, aA or AA, if you remember Mendel’s peas). So I also simulated that situation from the same dataset, but actually it made no difference to the findings. Nor did it make any difference if I allowed for correlations between the ‘genotypes’. Overall, I came away alarmed at just how often you can get spurious results from backwards stepwise regression – at least if you use the AIC criterion that is the default in the R package.



Lewis et al did one further analysis, generating an overall risk score based on the number of risk alleles (i.e. the version of the gene associated with lower IQ) for the four loci that were selected by the stepwise regression. This gave a significant association with child IQ, just in those who drunk in pregnancy: mean IQ was 104.0 (SD 15.8) for those with 4+ risk alleles, 105.4 (SD = 16.1) for those with 3 risk alleles and 107.5 (SD = 16.3) for those with 2 or less risk alleles. However, I was able to show very similar results from my analysis of random data: the problem here is that in a very large sample with many variables some associations will emerge as significant just by chance, and if you then select just those variables and add them up, you are capitalising on the chance effect.



One other thing intrigued me. The authors made a binary divide between those who reported drinking in pregnancy and those who did not. The category of drinker spanned quite a wide range from those who reported drinking less than 1 unit per week (either in the first 3 months or at 32 weeks of pregnancy) up to those who reported drinking up to 6 units per week. (Those drinking more than this were excluded, because the interest was in moderate drinkers). Now I’d have thought there would be interest in looking more quantitatively at the impact of moderate drinking, to see if there was a dose-response effect, with a larger effect of genotype on those who drank more. The authors mentioned a relevant analysis where the effect of genotype score on child IQ was greater after adjustment for amount drank at 32 weeks of pregnancy, but it is not clear whether this was a significant increase, or whether the same was seen for amount drank at 18 weeks. In particular, one cannot tell whether there is a safe amount to drink from the data reported in this paper. In a reply to my comment on the PLOS One paper, the first author states: “We have since re-run our analysis among the small group of women who reported drinking less than 1 unit throughout pregnancy and we found a similar effect to that which we reported in the paper.” But that suggests there is no dose-response effect for alcohol: I’m not an expert on alcohol effects, but I do find it surprising that less than one drink per week should have an effect on the foetal brain – though as the author points out, it’s possible that women under-reported their intake.



I’m also not a statistical expert and I hesitate to recommend an alternative approach to the analysis, though I am aware that there are multiple regression methods designed to avoid the pitfalls of stepwise regression. It will be interesting to see whether, as predicted by the authors, the genetic variants associated with lower IQ are those that predispose to slow alcohol metabolism. At the end of the day, the results will stand or fall according to whether they replicate in an independent sample.





Reference

Lewis SJ, Zuccolo L, Davey Smith G, Macleod J, Rodriguez S, Draper ES, Barrow M, Alati R, Sayal K, Ring S, Golding J, & Gray R (2012). Fetal Alcohol Exposure and IQ at Age 8: Evidence from a Population-Based Birth-Cohort Study. PloS one, 7 (11) PMID: 23166662

Wednesday, November 14, 2012

Are Starbucks hiding their profits on the planet Vulcan?







I just love the fact that the BBC have a Democracy Live channel where you can watch important government business. The Public Accounts Committee may sound incredibly dull, but I found this footage riveting. The committee grills executives from Starbucks, Amazon and Google about their tax arrangements. Quite apart from the content, it provides a wealth of material for anyone interested in how we interpret body language as a cue to a person's honesty. But for me it raised a serious issue about Starbucks. Is it run by aliens?




Tuesday, November 13, 2012

Flaky chocolate and the New England Journal of Medicine








Early in October a weird story hit the media: a nation’s chocolate consumption is predictive of its number of Nobel prize-winners, after correcting for population size. This is the kind of kooky statistic that journalists  love, and the story made a splash. But was it serious? Most academics initially assumed not. The source of the story was the New England Journal of Medicine, an august publication with stringent standards, which triages a high proportion of submissions that don’t get sent out for review. (And don't try asking for an explanation of why you’ve been triaged). It seemed unlikely that a journal with such exacting standards would give space to a lightweight piece on chocolate. So the first thought was that the piece had been published to make a point about the dangers of assuming causation from correlation, or the inaccuracies that can result when a geographical region is used as the unit of analysis. But reading the article more carefully gave one pause. It did have a somewhat jocular tone. Yet if this was intended as a cautionary tale, we might have expected it to be accompanied by some serious discussion of the methodological and interpretive problems with this kind of analysis. Instead, beneficial effects of dietary flavanols was presented as the most plausible explanation of the findings.



The author, cardiologist Franz Messerli, did discuss the possibility of a non-causal explanation for the findings, only to dismiss it. He stated “as to a third hypothesis, it is difficult to identify a plausible common denominator that could possibly drive both chocolate consumption and the number of Nobel laureates over many years. Differences in socioeconomic status from country to country and geographic and climatic factors may play some role, but they fall short of fully explaining the close correlation observed.” And how do we know “they fall short?” Well, because the author, Dr Messerli, says so.



As is often the case, the blogosphere did a better job of critiquing the paper than the journal editors and reviewers (see, for instance, here and here). The failure to consider seriously the role of a third explanatory variable was widely commented on, but, as far as I am aware, nobody actually did the analysis that Messerli should have done. I therefore thought I'd give it a go. Messerli explained where he’d got his data from – a chocolatier’s website and Wikipedia – so it was fairly straightforward to reproduce them (with some minor differences due to missing data from one chocolate website that's gone offline). Wikipedia helpfully also provided data on gross domestic product (GDP) per head for different nations, and it was easy to find another site with data on proportion of GDP spend on education (except China, which has figures here). So I re-ran the analysis, computing the partial correlation between chocolate consumption and Nobel prizes after adjusting for spend per head on education. When education spend was partialled out, the correlation dropped from .73 to .41, just falling short of statistical significance.



Since Nobel laureates typically are awarded their prizes only after a long period of achievement, a more convincing test of the association would be based on data on both chocolate consumption and education spend from a few decades ago. I’ve got better things to do than to dig out the figures, but I suggest that Dr Messerli might find this a useful exercise.



Another point to note is that the mechanism proposed by Dr Messerli involves an impact of improved cardiovascular fitness on cognitive function. The number of Nobel laureates is not the measure one would pick if setting out to test this hypothesis. The topic of national differences in ability is a contentious and murky one, but it seemed worth looking at such data as are available on the web to see what the chocolate association looks like when a more direct measure is used. For the same 22 countries, the correlation between chocolate consumption and estimated average cognitive ability is nonsignificant at .24, falling to .13 when education spend is partialled out.



I did write a letter to the New England Journal of Medicine reporting the first of my analyses (all there was room for: they allow you 175 words), but, as expected, they weren't interested. "I am sorry that we will not be able to print your recent letter to the editor
regarding the Messerli article of 18-Oct-2012." they wrote. "The space available for
correspondence is very limited, and we must use our judgment to present a
representative selection of the material received."



It took me all of 45 minutes to extract the data and run these analyses. So why didn’t Dr Messerli do this? And why did the NEJM editor allow him to get away with asserting that third variables “fall short” when it’s so easy to check it out? Could it be that in our celebrity-obsessed world, the journal editors think that there’s no such thing as bad publicity?



Messerli, F. (2012). Chocolate Consumption, Cognitive Function, and Nobel Laureates New England Journal of Medicine, 367 (16), 1562-1564 DOI: 10.1056/NEJMon1211064